NOVAST LABS FDA Approval ANDA 210614

ANDA 210614

NOVAST LABS

FDA Drug Application

Application #210614

Application Sponsors

ANDA 210614NOVAST LABS

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET, EXTENDED RELEASE;ORAL30MG0NIFEDIPINENIFEDIPINE
002TABLET, EXTENDED RELEASE;ORAL60MG0NIFEDIPINENIFEDIPINE
003TABLET, EXTENDED RELEASE;ORAL90MG0NIFEDIPINENIFEDIPINE

FDA Submissions

UNKNOWN; ORIG1AP2019-03-12STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB2
002PrescriptionAB2
003PrescriptionAB2

CDER Filings

NOVAST LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210614
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"NIFEDIPINE","activeIngredients":"NIFEDIPINE","strength":"30MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NIFEDIPINE","activeIngredients":"NIFEDIPINE","strength":"60MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NIFEDIPINE","activeIngredients":"NIFEDIPINE","strength":"90MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/12\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-03-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.